Click Therapeutics is a New York-based biotechnology company that specializes in developing and commercializing software as prescription medical treatments for individuals with unmet medical needs. Their digital therapeutics are designed to be used independently or in conjunction with biomedical treatments, utilizing cognitive and neurobehavioral mechanisms to enable change within individuals. Through their innovative approach, Click Therapeutics aims to help patients achieve a healthier and happier life by targeting the thoughts, sensations, emotions, and behaviors that define their condition.
As a regulated Software as a Medical Device (SaMD) company, Click Therapeutics develops their applications in accordance with FDA, ISO, and IEC standards. They undergo rigorous randomized, controlled trials to clinically validate the safety and efficacy of their applications, seeking FDA clearance as class II medical devices with independent therapeutic treatment claims or as adjuncts to existing therapy. Physicians prescribe their apps, payers reimburse for them, and Click Therapeutics continuously generates and applies real-world evidence to personalize and improve their applications.
Generated from the website